What Solutions We Provide:


  • Treatment Patterns

    • Detailed business rules to identify lines of treatment, adaptable to different indications
    • Distribution of mono and combination regimens in various lines
    • Treatment sequencing – predecessor, successor regimens
    • Identification of patients who have failed treatment with specific regimens of interest

  • Outcomes

    • Effectiveness outcomes (OS, TPFS, TTTD, TTNT, TTTDS)
    • Safety outcomes (AE occurrence rate, acute care events, OP-35)
    • Comparative effectiveness – within RWD, between RWD and clinical trial data
    • Synthetic control arm from RWD

  • Burden of Illness

    • Epidemiological – incidence, prevalence
    • Cost (to payer, to patient, by line, of regimen failure)
    • HRU
    • Comorbidities, concomitant medications

Examples of RWD-Based Studies Conducted in the Recent Past
Disease and treatment characteristics of men diagnosed with metastatic hormone-sensitive prostate cancer in real life: analysis from a commercial claims database
Treatment patterns and outcomes analysis in diffuse large B-cell lymphoma
A population-based study of the association of PSA doubling time (PSADT) with metastasis-free survival (MFS) and overall survival (OS) in non-metastatic CRPC patients
Utilization of hypomethylating agents and associated outcomes in elderly acute myeloid leukemia (AML) patients
Duration of treatment of multiple myeloma regimens in patients with relapsed or refractory multiple myeloma
Treatment sequencing patterns observed in atopic dermatitis patients
Evaluation of efficacy outcomes among follicular lymphoma treated patients in a real-world setting
Treatment patterns and comorbidities analysis of patients with small cell lung cancer in a large EMR database
Burden of illness and extent of hospitalization in RSV
Patient journey across the diagnostic and treatment path in lupus and PsE